ULTRACHOICE™ 8

Pfizer Animal Health

Bacterin-Toxoid

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

U.S. Vet. Lic. No.: 189

Description: This product consists of killed, standardized cultures of Clostridium chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D, with a special, water-soluble adjuvant Stimugen™).

Contains formalin as preservative.

Indications: For use in healthy cattle and sheep as an aid in preventing blackleg caused by Cl. chauvoei; malignant edema caused by Cl. septicum; bacillary hemoglobinuria caused by Cl. haemolyticum; black disease caused by Cl. novyi; gas-gangrene caused by Cl. sordellii; and enterotoxemia and enteritis caused by Cl. perfringens types B, C, and D. Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D.

Directions: Shake well. Cattle: Aseptically administer 2 mL. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (SC) under the skin. Healthy cattle should receive 2 doses administered 4-6 weeks apart. Sheep: Aseptically administer 1 mL subcutaneously in the neck, followed by a second dose 4-6 weeks later. For Cl. haemolyticum repeat the dose every 6 months in animals subject to reexposure. Annual revaccination with a single dose is recommended.

Precaution(s): Store at 2°-7°C. Do not freeze. Use entire contents when first opened.

Caution(s): Temporary local swelling at injection site may occur after administration. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Warning(s): Do not vaccinate within 21 days before slaughter.